Financhill
Buy
68

HCSG Quote, Financials, Valuation and Earnings

Last price:
$14.21
Seasonality move :
3.34%
Day range:
$14.12 - $14.84
52-week range:
$9.13 - $14.90
Dividend yield:
0%
P/E ratio:
25.36x
P/S ratio:
0.60x
P/B ratio:
2.01x
Volume:
560.2K
Avg. volume:
785.4K
1-year change:
30.28%
Market cap:
$1B
Revenue:
$1.7B
EPS (TTM):
$0.56

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HCSG
Healthcare Services Group
$443.9M $0.19 5.59% -10.7% $15.00
DVA
DaVita
$3.2B $2.02 5.28% 10.44% $163.01
EHC
Encompass Health
$1.4B $1.19 9.58% 7.68% $130.09
SGRY
Surgery Partners
$777.1M $0.05 7.29% 31.79% $31.45
TOI
The Oncology Institute
$119.5M -$0.10 14.19% -52.63% $7.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HCSG
Healthcare Services Group
$14.20 $15.00 $1B 25.36x $0.00 0% 0.60x
DVA
DaVita
$138.19 $163.01 $10.4B 13.70x $0.00 0% 0.91x
EHC
Encompass Health
$118.90 $130.09 $12B 24.57x $0.17 0.56% 2.20x
SGRY
Surgery Partners
$22.80 $31.45 $2.9B -- $0.00 0% 0.91x
TOI
The Oncology Institute
$3.02 $7.00 $269.5M -- $0.00 0% 0.57x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HCSG
Healthcare Services Group
-- 0.375 -- 2.52x
DVA
DaVita
102.82% 2.041 70.83% 1.12x
EHC
Encompass Health
53.38% 0.354 22.48% 0.84x
SGRY
Surgery Partners
67.11% 0.552 72.6% 1.40x
TOI
The Oncology Institute
93.58% -6.707 72.89% 1.50x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HCSG
Healthcare Services Group
$68M $21.5M 8.14% 8.45% 5.43% $25.8M
DVA
DaVita
$983.9M $433.3M 7.42% 38.96% 13.07% $36.8M
EHC
Encompass Health
$630.9M $267M 9.36% 18.4% 18.58% $125.5M
SGRY
Surgery Partners
$161.9M $89.6M -2.86% -5.45% 7.98% -$16.7M
TOI
The Oncology Institute
$17.2M -$9.9M -60.54% -340.01% -13.42% -$5.3M

Healthcare Services Group vs. Competitors

  • Which has Higher Returns HCSG or DVA?

    DaVita has a net margin of 3.85% compared to Healthcare Services Group's net margin of 5.05%. Healthcare Services Group's return on equity of 8.45% beat DaVita's return on equity of 38.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCSG
    Healthcare Services Group
    15.18% $0.23 $514.2M
    DVA
    DaVita
    30.52% $2.00 $11.4B
  • What do Analysts Say About HCSG or DVA?

    Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.63%. On the other hand DaVita has an analysts' consensus of $163.01 which suggests that it could grow by 17.96%. Given that DaVita has higher upside potential than Healthcare Services Group, analysts believe DaVita is more attractive than Healthcare Services Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    HCSG
    Healthcare Services Group
    2 3 0
    DVA
    DaVita
    1 8 0
  • Is HCSG or DVA More Risky?

    Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison DaVita has a beta of 1.141, suggesting its more volatile than the S&P 500 by 14.065%.

  • Which is a Better Dividend Stock HCSG or DVA?

    Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DaVita offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. DaVita pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HCSG or DVA?

    Healthcare Services Group quarterly revenues are $447.7M, which are smaller than DaVita quarterly revenues of $3.2B. Healthcare Services Group's net income of $17.2M is lower than DaVita's net income of $162.9M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.36x while DaVita's PE ratio is 13.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 0.91x for DaVita. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCSG
    Healthcare Services Group
    0.60x 25.36x $447.7M $17.2M
    DVA
    DaVita
    0.91x 13.70x $3.2B $162.9M
  • Which has Higher Returns HCSG or EHC?

    Encompass Health has a net margin of 3.85% compared to Healthcare Services Group's net margin of 10.41%. Healthcare Services Group's return on equity of 8.45% beat Encompass Health's return on equity of 18.4%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCSG
    Healthcare Services Group
    15.18% $0.23 $514.2M
    EHC
    Encompass Health
    43.35% $1.48 $5.4B
  • What do Analysts Say About HCSG or EHC?

    Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.63%. On the other hand Encompass Health has an analysts' consensus of $130.09 which suggests that it could grow by 9.41%. Given that Encompass Health has higher upside potential than Healthcare Services Group, analysts believe Encompass Health is more attractive than Healthcare Services Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    HCSG
    Healthcare Services Group
    2 3 0
    EHC
    Encompass Health
    10 0 0
  • Is HCSG or EHC More Risky?

    Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison Encompass Health has a beta of 0.930, suggesting its less volatile than the S&P 500 by 7.02%.

  • Which is a Better Dividend Stock HCSG or EHC?

    Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.56% to investors and pays a quarterly dividend of $0.17 per share. Healthcare Services Group pays -- of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HCSG or EHC?

    Healthcare Services Group quarterly revenues are $447.7M, which are smaller than Encompass Health quarterly revenues of $1.5B. Healthcare Services Group's net income of $17.2M is lower than Encompass Health's net income of $151.5M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.36x while Encompass Health's PE ratio is 24.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 2.20x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCSG
    Healthcare Services Group
    0.60x 25.36x $447.7M $17.2M
    EHC
    Encompass Health
    2.20x 24.57x $1.5B $151.5M
  • Which has Higher Returns HCSG or SGRY?

    Surgery Partners has a net margin of 3.85% compared to Healthcare Services Group's net margin of -4.86%. Healthcare Services Group's return on equity of 8.45% beat Surgery Partners's return on equity of -5.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCSG
    Healthcare Services Group
    15.18% $0.23 $514.2M
    SGRY
    Surgery Partners
    20.86% -$0.30 $7.1B
  • What do Analysts Say About HCSG or SGRY?

    Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.63%. On the other hand Surgery Partners has an analysts' consensus of $31.45 which suggests that it could grow by 37.96%. Given that Surgery Partners has higher upside potential than Healthcare Services Group, analysts believe Surgery Partners is more attractive than Healthcare Services Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    HCSG
    Healthcare Services Group
    2 3 0
    SGRY
    Surgery Partners
    8 3 0
  • Is HCSG or SGRY More Risky?

    Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison Surgery Partners has a beta of 1.961, suggesting its more volatile than the S&P 500 by 96.073%.

  • Which is a Better Dividend Stock HCSG or SGRY?

    Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. Surgery Partners pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HCSG or SGRY?

    Healthcare Services Group quarterly revenues are $447.7M, which are smaller than Surgery Partners quarterly revenues of $776M. Healthcare Services Group's net income of $17.2M is higher than Surgery Partners's net income of -$37.7M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.36x while Surgery Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 0.91x for Surgery Partners. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCSG
    Healthcare Services Group
    0.60x 25.36x $447.7M $17.2M
    SGRY
    Surgery Partners
    0.91x -- $776M -$37.7M
  • Which has Higher Returns HCSG or TOI?

    The Oncology Institute has a net margin of 3.85% compared to Healthcare Services Group's net margin of -18.76%. Healthcare Services Group's return on equity of 8.45% beat The Oncology Institute's return on equity of -340.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCSG
    Healthcare Services Group
    15.18% $0.23 $514.2M
    TOI
    The Oncology Institute
    16.52% -$0.21 $79M
  • What do Analysts Say About HCSG or TOI?

    Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.63%. On the other hand The Oncology Institute has an analysts' consensus of $7.00 which suggests that it could grow by 131.79%. Given that The Oncology Institute has higher upside potential than Healthcare Services Group, analysts believe The Oncology Institute is more attractive than Healthcare Services Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    HCSG
    Healthcare Services Group
    2 3 0
    TOI
    The Oncology Institute
    1 0 0
  • Is HCSG or TOI More Risky?

    Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HCSG or TOI?

    Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HCSG or TOI?

    Healthcare Services Group quarterly revenues are $447.7M, which are larger than The Oncology Institute quarterly revenues of $104.4M. Healthcare Services Group's net income of $17.2M is higher than The Oncology Institute's net income of -$19.6M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.36x while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 0.57x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCSG
    Healthcare Services Group
    0.60x 25.36x $447.7M $17.2M
    TOI
    The Oncology Institute
    0.57x -- $104.4M -$19.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will DigitalOcean Stock Bounce Back?
Will DigitalOcean Stock Bounce Back?

DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…

Where Will Cognizant Stock Be In 5 Years?
Where Will Cognizant Stock Be In 5 Years?

Cognizant Technologies (NASDAQ:CTSH) is a global provider of IT services…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
60
MRUS alert for May 24

Merus NV [MRUS] is up 32.55% over the past day.

Buy
57
RGC alert for May 24

Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.

Buy
90
OKLO alert for May 24

Oklo [OKLO] is up 23.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock